AI News
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
The DeepMind spinout secures a $5 billion Series C to advance its drug-discovery ambitions.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
TA
TechCrunch AI
Source
TechCrunch AI

AI Analysis
Generated insight by OnAirToday AI
A $5 billion Series C gives Isomorphic Labs substantial backing for its effort to advance drug candidates toward clinical trials. The company’s origins at DeepMind connect its drug-discovery work to a prominent AI research organization.
Powered by AI • Not a substitute for human analysisMore Insights →
Share
Filed under:AI News

Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.